Study With QR-504a to Evaluate Safety, Tolerability & Corneal Endothelium Molecular Biomarker(s) in Subjects With FECD3

Clinical trial NCT05052554 · WITHDRAWN

Trial details

NCT number: NCT05052554
Sponsor: ProQR Therapeutics
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Fuchs Endothelial Corneal Dystrophy FECD3 Corneal Diseases LRS Descemet's Membrane Disorder

Start date: 2021-08-10
Primary completion: 2022-04-12
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.